The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
VEXPX | |
Total Expense Ratio | 0.44 |
Annual Report Gross Expense Ratio | 0.44 |
Fund Existence | 58 years |
Gain YTD | 4.828 |
Front Load | N/A |
Min. Initial Investment | 3000 |
Min. Initial Investment IRA | N/A |
Net Assets | 20.5B |
Annual Yield % from dividends | 0.39 |
Returns for 1 year | 0.69 |
Returns for 3 years | 21.90 |
Returns for 5 years | 11.42 |
Returns for 10 years | 32.23 |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ZALT | 31.76 | 0.04 | +0.13% |
Innovator U.S. Equity 10 Buffr ETF - Qt | |||
SVAL | 33.99 | 0.01 | +0.03% |
iShares US Small Cap Value Factor ETF | |||
XTAP | 39.47 | N/A | N/A |
Innovator US Equity Acltd Pls ETF™ April | |||
SJLD | 25.51 | N/A | N/A |
SanJac Alpha Low Duration ETF | |||
XBI | 93.43 | -0.69 | -0.73% |
SPDR® S&P Biotech ETF |